Filing Flows › Health Catalyst (HCAT) › Q2 2026 › vs Q1 2026
Health Catalyst (HCAT) Q2 2026 vs Q1 2026 (quarter over quarter)
Health Catalyst's revenue fell $269K (-0.4%) from $70.8M in Q1 2026 to $70.5M in Q2 2026. The biggest changes: Technology −$673K (-1%); Accumulated Impairment Losses +$404K (+2%).
Health Catalyst, Q2 2026: revenue $70.5M (-13% year over year), operating margin -51.8%, net loss $40.5M, operating cash flow $275K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Technology | $48.8M | $49.5M | −$673K | -1% |
| Accumulated Impairment Losses | $21.7M | $21.3M | $404K | +2% |
| Revenue | $70.5M | $70.8M | −$269K | -0.4% |
| Net loss | $40.5M | $111M | −$70.5M | -63% |
| Costs & expenses | $111M | $182M | −$70.8M | -39% |
| Operating costs | $107M | $177M | −$70.3M | -40% |
| Interest & other, net | $3.7M | $4.1M | −$393K | -10% |
| Income tax | $315K | $414K | −$99K | -24% |
| Cost of revenue | $35.6M | $35.3M | $334K | +0.9% |
| Research & development | $11.0M | $9.8M | $1.2M | +13% |
| Sales & marketing | $10.4M | $10.6M | −$225K | -2% |
| General & admin | $11.9M | $14.0M | −$2.0M | -15% |
| Other operating costs | $38.0M | $108M | −$69.6M | -65% |
| Operating cash sources | $40.8M | $130M | −$88.7M | -68% |
| Depreciation & amortization | $11.0M | $12.1M | −$1.1M | -9% |
| Share-based compensation | $2.7M | $3.8M | −$1.1M | -28% |
| Working capital & other | $27.1M | $114M | −$86.5M | -76% |
| Net loss absorbed | $40.5M | $111M | −$70.5M | -63% |
| Operating cash flow | $275K | $18.5M | −$18.2M | -99% |
| Capital expenditures | $345K | $338K | $7K | +2% |
| Negative free cash flow (OCF − capex) | $70K | −$18.2M | $18.2M | — |
Questions
How much did Health Catalyst's revenue grow quarter over quarter in Q2 2026?
Health Catalyst's revenue fell $269K (-0.4%) from $70.8M in Q1 2026 to $70.5M in Q2 2026.
What drove Health Catalyst's revenue change in Q2 2026?
Technology −$673K (-1%); Accumulated Impairment Losses +$404K (+2%).